Question 1

What is pharma marketing analytics?

Accepted Answer

Pharma marketing analytics connects biopharma digital marketing activity to business outcomes — tracking which programs drive qualified treatment center searches, HCP engagement, and patient conversion, and translating that into ROI metrics leadership can act on. Unlike consumer analytics, it operates within HIPAA, GDPR, and FDA fair balance requirements from day one.

Question 2

What is AEO for biopharma?

Accepted Answer

AEO (Answer Engine Optimization) for biopharma means structuring content so AI tools like Google AI Overviews cite your brand when patients and HCPs search. It requires MLR-compliant structured data, FAQ schema, and content architecture designed for how generative AI extracts and attributes answers.

Question 3

What is proxy ROAS and why does biopharma need it?

Accepted Answer

Proxy ROAS assigns dollar values to conversion events — treatment center locator searches, HCP rep requests, patient support enrollments — creating an ROI signal that connects digital spend to business outcomes without requiring HIPAA-restricted patient data.

Question 4

Does PharmaForward work alongside existing agencies?

Accepted Answer

Yes — and it's the norm. Most clients have an AOR, a media agency, and a development partner already in place. PharmaForward operates as the independent analytics and strategy layer without competing for scope. Reports go directly to the client.

Question 5

What does a typical engagement look like?

Accepted Answer

Most engagements begin with a measurement or performance audit — two to four weeks that produce a prioritized roadmap. A 90-day sprint addresses the highest-priority work. Ongoing retainer covers the rest. All engagements are explicitly scoped.

This page moved, or never existed.